Ghent is boosting its biopharma hub with cutting-edge infrastructure, world-class research, and a thriving life sciences ...
Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in oncology ...
Objective response rate (ORR) of 75.0% including three very good partial responses (VGPR) in heavily pre-treated Waldenström ...
NEET UG 2026 is expected on the first Sunday of May. Check your preparation with these high-yield Plant Physiology ...
Investor's Business Daily on MSN
How stock of the day Genmab is leveraging an $8 billion deal to stoke its next chapter
Genmab stock, Thursday's IBD Stock Of The Day, is just below an early entry in a cup case after announcing an $8 billion deal ...
MediaKind, a global leader in cloud-based video streaming technology, today announced it has entered into an agreement to acquire the Video Business of Harmonic Inc. for approximately $145 million.
The Galien Foundation, a global institution committed to recognizing collaborative scientific and medical innovations that advance patient care, celebrated the inaugural Prix Galien Bridges Awards on ...
Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...
The Ontario government is welcoming an investment of over $138 million from AtomVie Global Radiopharma Inc., a homegrown, leading manufacturer of radiopharmaceuticals, to expand its f ...
Objective response rate (ORR) of 83% including two complete responses in CLL patients in Phase 1a study with median progression free survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback